Zobrazeno 1 - 10
of 48
pro vyhledávání: '"Karin, Dilger"'
Publikováno v:
JIMD Reports, Vol 64, Iss 1, Pp 23-26 (2023)
Abstract Eliglustat is an orphan medicine used for long‐term treatment of Gaucher disease type 1 (GD1) in adults. GD1 is a genetic condition, in which glucosylceramide builds up in the body, typically in liver, spleen, and bone. Clinical signs and
Externí odkaz:
https://doaj.org/article/2b3b9008d3264ffb826b5843e6da1875
Publikováno v:
JIMD Reports. 64:23-26
Autor:
Nicholas J. Talley, János Banai, Juris Pokrotnieks, M. M. Diez Alonso, Rifaat Safadi, J. Derova, Zsolt Tulassay, I. Bunganic, J. Kondrackiene, T. Vich, Salam Zakko, J. Mäkelä, Ralf Mohrbacher, Karin Dilger, Wolfgang Kruis, D. Tuculanu, N. Ferreira, Roland Greinwald, Austin Curtin, Milan Lukas, S. Björck, T. Eisenbach, Andrey E. Dorofeyev, Vassilios Kardalinos, Robin C. Spiller
Publikováno v:
Alimentary Pharmacology & Therapeutics
SummaryBackground Previous studies have reached conflicting conclusions regarding the efficacy of mesalazine in the prevention of recurrent diverticulitis. Aim To investigate the efficacy and safety of mesalazine granules in the prevention of recurre
Autor:
Tanju Nacak, Vladimir Vasilievich Pavlenko, Jacek Artur Romatowski, Roland Greinwald, Andrey E. Dorofeyev, Laimas Virginijus Jonaitis, Jelena Derova, Axel Dignass, Robert Schnabel, Karin Dilger
Background Adherence to mesalazine treatment is essential for the successful treatment of ulcerative colitis. Objective The objective of this study was to compare the efficacy, safety and preference of a novel high-dose 1000 mg mesalazine tablet vers
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1ff017f0954ce7cc362f819831496ddd
https://europepmc.org/articles/PMC5802664/
https://europepmc.org/articles/PMC5802664/
Autor:
Ralph Mueller, Andreas Münch, Curt Tysk, Stephan Miehlke, Cecilia Benoni, Magnus Ström, Søren Avnstrøm, Greger Lindberg, Erik Hertervig, Martin Rössle, Karin Dilger, A. Lapidus, Jan Björk, Martin Olesen, Per M. Hellström, Åke Öst, Jiri Stehlik, Peter Armerding, Ole K. Bonderup, Roland Greinwald, Robert Löfberg, Johan Bohr, Lars Strandberg
Publikováno v:
Münch, A, Bohr, J, Miehlke, S, Benoni, C, Olesen, M, Ost, A, Strandberg, L, Hellström, P M, Hertervig, E, Armerding, P, Stehlik, J, Lindberg, G, Björk, J, Lapidus, A, Löfberg, R, Bonderup, O, Avnström, S, Rössle, M, Dilger, K, Mueller, R, Greinwald, R, Tysk, C, Ström, M & on behalf of the BUC-63 investigators 2016, ' Low-dose budesonide for maintenance of clinical remission in collagenous colitis : a randomised, placebo-controlled, 12-month trial ', Gut, vol. 65, pp. 47-56 . https://doi.org/10.1136/gutjnl-2014-308363
Gut
Gut
OBJECTIVE: This 1-year study aimed to assess low-dose budesonide therapy for maintenance of clinical remission in patients with collagenous colitis.DESIGN: A prospective, randomised, placebo-controlled study beginning with an 8-week open-label induct
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::09f001cdd1802c88d08c6828c4679da2
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-274273
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-274273
Publikováno v:
Arzneimittelforschung. 51:891-895
The effect of the non-steroidal anti-inflammatory drug lysine clonixinate ([2-(3-chloro-o-toluidino)nicotinic acid]-L-lysinate, CAS 55837-30-4) on the pharmacokinetics and anticoagulant activity of phenprocoumon (4-hydroxy-3-(1-phenylpropyl)-coumarin
Autor:
T. L. Mikhailova, Wolfgang Kruis, Ralph Mueller, M. Bátovský, M. Faszczyk, Y. Zakharash, Karin Dilger, István Rácz, Laimas Virginijus Jonaitis, Marek Horynski, Aleksandar Včev, Juris Pokrotnieks, Y. S. Lozynsky, K. Kull, Roland Greinwald
Publikováno v:
Alimentary Pharmacology & Therapeutics. 33:313-322
Aliment Pharmacol Ther 2011; 33: 313–322 Summary Background Comparative data regarding different regimens of oral mesalazine (mesalamine) for maintaining remission in ulcerative colitis are limited. Aim To evaluate whether 3.0 g mesalazine once-dai
Autor:
Tilo, Andus, Andreas, Kocjan, Moritz, Müser, Andrey, Baranovsky, Tatyana L, Mikhailova, Tatyana D, Zvyagintseva, Andrey E, Dorofeyev, Yurii S, Lozynskyy, Ingolf, Cascorbi, Manfred, Stolte, Michael, Vieth, Karin, Dilger, Ralf, Mohrbacher, Roland, Greinwald, A, Tromm
Publikováno v:
Inflammatory Bowel Diseases. 16:1947-1956
Background: Mesalamine suppositories are first-line therapy in active ulcerative proctitis; the standard regime still recommends multiple doses per day. The primary objective of this study was to show the noninferiority of once-daily administration o
Autor:
Walter, Reinisch, Sieglinde, Angelberger, Wolfgang, Petritsch, Olga, Shonova, Milan, Lukas, Simon, Bar-Meir, Alexander, Teml, Elke, Schaeffeler, Matthias, Schwab, Karin, Dilger, Roland, Greinwald, Ralph, Mueller, Eduard F, Stange, Klaus R, Herrlinger, Shmuel, Odes
Publikováno v:
Gut. 59:752-759
The aim of the study was to compare azathioprine versus mesalazine tablets for the prevention of clinical recurrence in patients with postoperative Crohn's disease (CD) with moderate or severe endoscopic recurrence.This was a 1 year, double-blind, do
Publikováno v:
Biology of Blood and Marrow Transplantation. 15(3):336-343
Buccal administration of budesonide (mouthwash) may be effective as a topical add-on therapy in patients with oral chronic graft-versus-host disease (cGVHD). Safety of approved oral budesonide is based on high intestinal and hepatic extraction by cyt